National and International regulatory advice on the development and commercial production of biological products is provided by a former US FDA CBER reviewer and certified FDA inspector, trained in regulatory affairs, product manufacturing and testing and facility inspections.Merfyn Williams received his regulatory affairs training while at the US FDA Center for Biologics Evaluation and Research where he also became a qualified inspector of Facilities and biologics' production. He has worked with health authorities in Kuwait, Bahrain, India and Egypt. His industry experience spans more than twenty years and has been in both large pharma and small start-up companies both in the US and Europe.